Choriogonadotropin alfa biosimilar (Suzhou Shengji Pharma)

重组人绒促性素生物类似药 (苏州晟济）

Report date: 2024/06/04 16:19:26

Base Information

Drug NameChoriogonadotropin alfa biosimilar (Suzhou Shengji Pharma)
Drug Alias NameN/A
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionOvarian follicle stimulantsLuteinizing hormone/Choriogonadotropin receptor agonists
TargetsLuteinizing hormone/Choriogonadotropin receptor
Therapy Area/IndicationsInfertility, FemaleAnovulation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSuzhou Shengji Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Shengji Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsInfertility, FemaleAnovulation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A